Form 8-K AMEDISYS INC For: Aug 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
UPDATE: Amedisys (AMED) Reports In-Line EPS, Revenue Tops Views; CFO to Retire
August 2, 2016 5:19 PM EDT(Updated - August 2, 2016 5:47 PM EDT)
(Update corrects for adjusted EPS figure)
Amedisys (NASDAQ: AMED) reported Q2 EPS of $0.42 vs consensus of $0.42. Revenue for the quarter came in at $360 million versus the consensus estimate of $353.07 million.
Executive Retirement
On August 2, 2016, Ronald A. LaBorde, the Vice Chairman and... More
